David L McKinzie

Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.

Ben Grayson, John M Schaus, F. Bymaster, 2010, The international journal of neuropsychopharmacology.

Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia.

Craig Mallinckrodt, Anantha Shekhar, Christian C Felder, 2008, The American journal of psychiatry.

Muscarinic mechanisms in psychotic disorders.

F. Bymaster, D. McKinzie, David L McKinzie, 2012, Handbook of experimental pharmacology.

M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related central nervous system pathologies

J. Wess, K. Perry, F. Bymaster, 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.